{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:53:45Z","timestamp":1791860025424,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1002\/jps.20934","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T16:12:15Z","timestamp":1177431135000},"page":"996-1007","source":"Crossref","is-referenced-by-count":22,"title":["PHARMACEUTICS, PREFORMULATION ANDDRUG DELIVERY"],"prefix":"10.1016","volume":"96","author":[{"given":"Mino R.","family":"Caira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Bettinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Sorrenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Catenacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20934_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jps.10034","article-title":"Structural relationships, thermal properties and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim","volume":"91","author":"Caira","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20934_bb0015","first-page":"411","article-title":"Brodimoprim: Adverse drug reactions from spontaneous reporting","volume":"44","author":"Conforti","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.20934_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0301-2115(95)02292-9","article-title":"Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: Comparative study vs. pefloxacin","volume":"64","author":"Cosmi","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/jps.20934_bb0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0924-8579(99)00080-1","article-title":"In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae","volume":"12","author":"Dhople","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1002\/jps.20934_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/47.1.93","article-title":"Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans","volume":"47","author":"Dhople","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.20934_bb0035","article-title":"The Merck index: An encyclopedia of chemicals, drugs, and biologicals","year":"2001"},{"key":"10.1002\/jps.20934_bb0040","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1002\/hlca.19770600854","article-title":"Synthese von 4-halogensubstituierten analogen von trimethoprim","volume":"60","author":"Kompis","year":"1977","journal-title":"Helv Chim Acta"},{"key":"10.1002\/jps.20934_bb0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/1120009X.1993.11741089","article-title":"Comparative antibacterial spectrum of trimethoprim and brodimoprim","volume":"5","author":"Amyes","year":"1993","journal-title":"J Chemother"},{"key":"10.1002\/jps.20934_bb0050","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1128\/AAC.40.12.2865","article-title":"Trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophils","volume":"40","author":"Fresta","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20934_bb0055","series-title":"Delft","year":"2000"},{"key":"10.1002\/jps.20934_bb0060","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","author":"Otwinowski","year":"1997"},{"key":"10.1002\/jps.20934_bb0065","series-title":"Crystallographic computing 3","first-page":"175","article-title":"SHELXS86","author":"Sheldrick","year":"1985"},{"key":"10.1002\/jps.20934_bb0070","series-title":"SHELX-97: Program for the refinement of crystal structures. G\u00f6ttingen","author":"Sheldrick","year":"1997"},{"key":"10.1002\/jps.20934_bb0075","first-page":"C34","article-title":"PLATON: A multipurpose crystallographic tool","volume":"A46","author":"Spek","year":"1990","journal-title":"Acta Crystallogr"},{"key":"10.1002\/jps.20934_bb0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1107\/S0021889897003117","article-title":"ORTEP-3 for windows-A version of ORTEP-III with a graphical user interface (GUI)","volume":"30","author":"Farrugia","year":"1997","journal-title":"J Appl Crystallogr"},{"key":"10.1002\/jps.20934_bb0085","series-title":"WebLab ViewerPro 3.7","year":"2000"},{"key":"10.1002\/jps.20934_bb0090","series-title":"CRC Handbook of Chemistry and Physics","year":"1985"},{"key":"10.1002\/jps.20934_bb0095","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1021\/ja00424a009","article-title":"The crystal and molecular structure of the antifolate drug trimethoprim (2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine). A neutron diffraction study","volume":"98","author":"Koetzle","year":"1976","journal-title":"J Am Chem Soc"},{"key":"10.1002\/jps.20934_bb0100","series-title":"Polymorphism in Pharmaceutical Solids. Drugs and the pharmaceutical sciences, a series of textbooks and monographs","first-page":"144","article-title":"Structural aspects of hydrates and solvates","author":"Morris","year":"1999"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916322365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916322365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T13:55:41Z","timestamp":1587477341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916322365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0022354916322365"],"URL":"https:\/\/doi.org\/10.1002\/jps.20934","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}